Enterobacteriaceae with bla NDM-7 is only infrequently observed. Selftransmissible plasmids carrying the bla NDM gene increase the dissemination of carbapenem resistance in developing countries.
Introduction
Extended-spectrum β-lactamase (ESBL)-producing organisms pose unique challenges in community and clinical settings.
Carbapenems are known to be promising drugs for ESBLproducing organisms, but increasing resistance to carbapenems among Enterobacteriaceae has been reported. The prevalence of carbapenem-resistant Enterobacteriaceae in India has been reported to vary from 7 to 51%. Carbapenem-resistant Enterobacteriaceae has been associated with high mortality and morbidity rates of 40 to 50% [1] .
New Delhi metallo-β-lactamase (NDM) protein has an extensive pattern of spread as a result of its plasmid location. bla NDM-1 is the most prevalent variant among Enterobacteriaceae. However, bla NDM-4, bla NDM-5, bla NDM-7 and bla NDM-14 were reported to have enhanced hydrolytic activity compared to bla NDM-1 , although only a few cases were reported. Further, a wide range of Gram-negative genera containing diverse bla NDM -harbouring plasmids has been reported in >15 countries worldwide [2] . The various plasmid-borne bla NDM are listed in Table 1 .
Several studies have reported bla NDM-1 -carrying IncX3 plasmid in Enterobacteriaceae. The IncX3 plasmids carrying bla NDM-1 or bla NDM-5 were found to have identical backbones [9] . Therefore, patients infected or colonized with bacteria containing bla NDM-7 IncX3 plasmids will pose challenges to infection control compared to other bla NDM variants [11] .
Spread of antimicrobial resistance through plasmid has become common but is difficult to track. Outbreaks due to plasmid often go undetected, as this may occur among different genera or species. Thus, tracking is of greater medical importance to prevent the spread among other genera or species. Specific molecular techniques like next-generation sequencing will be handy to identify such plasmids. We report the draft genome sequence of bla NDM-7 -carrying, IncX3-positive Escherichia coli isolated from clinical blood specimen.
Methods

Bacterial strains
In total 773 E. coli isolates were obtained from blood specimen during the study period of January to December 2014. A total of 15.7% (n = 122) of these isolates were carbapenem resistant, of which a multidrug-resistant E. coli isolate (B37305) positive for bla NDM was selected for whole genome sequencing. The selected isolate was obtained from a patient, aged 65 years, who experienced complications related to a gallbladder carcinoma, who obtained care at Christian Medical College, Vellore, India.
tazobactam (100/10 μg), cefoperazone/sulbactam (75/30 μg), amikacin (30 μg), netilmicin (30 μg), gentamicin (10 μg), ciprofloxacin (5 μg), imipenem (10 μg) and meropenem (10 μg) according to Clinical and Laboratory Standards Institute (CLSI) 2014 guidelines [12] . Quality control strains used were E. coli ATCC 35218 for ampicillin and E. coli ATCC 25922 for rest of the antibiotics. The combined disc method of cefotaxime with/ without clavulanic acid for ESBL production was performed as recommended by CLSI 2014 [12] . Carbapenemase production was tested by the CarbaNP method as recommended by CLSI 2015 [13] .
CarbaNP test for detection of carbapenemase
The isolate was subjected to classical CarbaNP test using BPERII lysis; protocol was followed as previously described by Dortet et al. [14] .
Multiplex PCR for screening of β-lactamase genes Multiplex PCR for detection of ESBL genes bla TEM , bla SHV , bla PER and bla VEB were performed as mentioned previously [15] . AmpC (bla MOX , bla CIT , bla DHA , bla ACC , bla EBC , bla FOX ) and bla CTX-M-1 were tested using primers described earlier [16, 17] . Class A, B and D carbapenemase genes were screened by testing (bla KPC, bla GES, bla SPM , bla IMP, bla VIM, bla NDM and bla OXA-48 -like) [14, 15, [17] [18] [19] .
Whole genome sequencing
The genome was sequenced using Ion torrent (PGM; Life Technologies, Carlsbad, CA, USA) with 200 bp chemistry.
Isolation of genomic DNA was performed using QIAamp DNA mini kit (Qiagen, Hilden, Germany). The sequencing was performed as per the manufacturer's instructions.
Downstream bioinformatics analysis
Data obtained were assembled de novo using AssemblerSPAdes 4.4.0.1 software in Torrent suite server version 4.4.3. The sequence was annotated using Rapid Annotation using Subsystem Technology (RAST) pipeline [20] [21] [22] (http://rast.nmpdr. org/); PATRIC, the bacterial bioinformatics database and analysis resource [23] (http://www.patricbrc.org); and the National Center for Biotechnology Information Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP; http://www.ncbi.nlm. nih.gov/genomes/static/Pipeline.html). Downstream analysis was performed using the CGE server (http://www.cbs.dtu.dk/ services), RAST and PATRIC.
Results
Phenotypic characterization
The isolate B37305 was phenotypically resistant to gentamicin, piperacillin/tazobactam, cefoperazone/sulbactam, imipenem, meropenem, cefotaxime, ceftriaxone, ceftazidime and cefepime, and susceptible to amikacin, netilmicin and ciprofloxacin. The carbapenem resistance was confirmed by the CarbaNP test, and the isolate was phenotypically positive for ESBL production.
Molecular characterization
On the basis of these results, the multidrug-resistant E. coli (B37305) was selected for whole genome sequencing to identify the molecular mechanism behind the resistance pattern and the associated genes. The whole genome shotgun sequence has been deposited at DDBJ/ENA/GenBank under accession number LSAQ00000000. The version described here is version LSAQ01000000.
The strain was identified to be sequence type ST-167 using MLST 1.8 in the CGE server [24] . Presence of antimicrobial resistance genes such as bla NDM-7 , bla TEM-1B and bla CMY-42 were identified using the ResFinder 2.1 tool [25] . A self-transferable IncX3 plasmid was identified using PlasmidFinder 1.3 [26] . The genetic environment of bla NDM-7 is depicted in Fig. 1 . In addition, the PATRIC analysis revealed the presence of two β-lactamase enzymes that were previously reported as bla EC family class C β-lactamases (GenBank accession no. WP_039000307).
Discussion
Carbapenem resistance among Enterobacteriaceae is becoming a major problem, as this drug is known as being the therapy of last resort for serious infections caused by Gram-negative bacteria. As reported earlier, NDM is endemic to the Indian subcontinent but has spread worldwide. The prevalence rates of NDM-producing Enterobacteriaceae in India were found to be 5 to 18.5% [14] . E. coli-producing NDM carbapenemase have also been reported in Canada and Cameroon, as well as other Asian and European countries [27] . Further, the spread of ESBL producers is an important driving force for usage of carbapenems, which enhances the selection of carbapenemase producers [14] . The present study provides evidence that carbapenemase producers are often multidrug resistant and also coexpresses other antibiotic resistance genes which might be carried by the same plasmid.
In addition, Dortet et al. [14] reported the presence of an bla NDM-7 variant in E. coli. Similarly, a previous study from the literature investigated the first identification of bla NDM-7 in E. coli ST-167 [27] . There was a previous report of IncX3 plasmid carrying bla NDM-5 from India [8] . However, the identification of IncX3 carrying bla NDM-7 is the first to be so described in India.
This study emphasizes the importance of screening for bla NDM-7 and its associated plasmids. Because the IncX3 plasmid is known for its self-transmissible properties, association of bla NDM-7 with IncX3 enhances the dissemination potential. Further studies on expression levels of bla NDM-7 relating to severity of infection and patient outcome need to be conducted in order to better understand infection control.
